Improved survival for stage III/IV melanoma from an unknown primary site (MUP): An Italian multicentric study

被引：1
|
作者：
Guida, M.
Muggiano, A.
Albano, D.
Ridolfi, R.
Testori, A.
Chiarion-Sileni, V.
Sertoli, M. R.
Romanini, A.
Parmiani, G.
Colucci, G.
机构：
[1] Ist Oncol, Bari, Italy
[2] Osped Oncol Businco, Cagliari, Italy
[3] Natl Canc Inst, Dept Med Oncol, Bari, Italy
[4] IRST, Meldola, Italy
[5] European Inst Oncol, Melanoma & Muscle Cutaneous Sarcoma Div, Milan, Italy
[6] Ist Oncol Veneto, Padua, Italy
[7] Univ Genoa, Genoa, Italy
[8] Santa Chiara Univ Hosp Pisa, Pisa, Italy
[9] Ist Sci San Raffaele, Dept Oncol, I-20132 Milan, Italy
[10] Natl Canc Inst Bari, Med Oncol Unit, Bari, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e19025
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19025
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Improved survival in patients with Stage III-IV head and neck cancer treated with radiotherapy as primary local treatment modality
    Rusthoven, Kyle E.
    Raben, David
    Chen, Changhu
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (02): : 343 - 350
  • [42] Improved Survival with Immunotherapy but Lack of Synergistic Effect with Radiation for Stage IV Melanoma of the Head and Neck
    Babcock, Blake
    Rodrigues, Medora
    Kearns, Donovan
    Solomon, Naveenraj
    Reeves, Mark E.
    Senthil, Maheswari
    Garberoglio, Carlos A.
    Namm, Jukes P.
    AMERICAN SURGEON, 2019, 85 (10) : 1118 - 1124
  • [43] Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry
    Ozkan, A.
    Kapiteijn, E.
    van den Bos, F.
    Aarts, M. J. B.
    van den Berkmortel, F. W. P. J.
    Blank, C. U.
    Bloem, M.
    Blokx, W. A. M.
    Boers-Sonderen, M. J.
    Bonenkamp, J. J.
    van den Eertwegh, A. J. M.
    de Groot, J. W. B.
    Haanen, J. B.
    Holtslag, C. E.
    Hospers, G. A. P.
    Piersma, D.
    van Rijn, R. S.
    Boer, A. M. Stevense-den
    Suijkerbuijk, K. P. M.
    van der Veldt, A. A. M.
    Vreugdenhil, G.
    Wouters, M. W. J. M.
    Portielje, J. E. A.
    de Glas, N. A.
    EUROPEAN JOURNAL OF CANCER, 2024, 212
  • [44] NETWORK META-ANALYSIS UNDER SURVIVAL HETEROGENEITY WITH LONG-TERM SURVIVAL: A CASE STUDY FROM ADJUVANT TREATMENT OF RESECTED STAGE III/IV MELANOMA
    Toor, K.
    Goring, S.
    Chan, K.
    Kurt, M.
    Moshyk, A.
    Hamilton, M.
    Kotapati, S.
    Jansen, J. P.
    VALUE IN HEALTH, 2022, 25 (01) : S208 - S208
  • [45] Less Surgery, Improved Survival From Stage IV Colorectal Cancer?
    Price, Timothy J.
    Tebbutt, Niall
    Townsend, Amanda R.
    JAMA SURGERY, 2015, 150 (08) : 818 - 818
  • [46] AN ANALYSIS OF SKIN-TESTS AND THEIR RELATIONSHIP TO RECURRENCE AND SURVIVAL IN STAGE-III AND STAGE-IV MELANOMA PATIENTS
    LEE, ET
    ISHMAEL, DR
    BOTTOMLEY, RH
    MURRAY, JL
    CANCER, 1982, 49 (11) : 2336 - 2341
  • [47] A study of prognostic factors (PF) for survival in cancer of unknown primary site (CUPS).
    González, MCA
    Santiago, JA
    Arranz, JA
    Lahoz, C
    Chaib, C
    Afonso, R
    Pombo, L
    Fernández, I
    Pérez, HM
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S84 - S84
  • [48] Risk factors for survival from neuroendocrine neoplasia with unknown primary tumor site
    Begum, Nehara
    Wellner, Ulrich F.
    Thorns, Christoph
    Hoffmann, Martin
    Buerk, Conny G.
    Keck, Tobias
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (04) : E84 - E84
  • [49] Risk Factors for Survival from Neuroendocrine Neoplasia with Unknown Primary Tumor Site
    Begum, N.
    Wellner, U.
    Thorns, C.
    Hoffmann, M.
    Buerk, C.
    Brabant, G.
    Lehnert, H.
    Keck, T.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 139 - 139
  • [50] Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma
    Geoerger, Birgit
    Bergeron, Christophe
    Gore, Lia
    Sender, Leonard
    Dunkel, Ira J.
    Herzog, Cynthia
    Brochez, Lieve
    Cruz, Ofelia
    Nysom, Karsten
    Berghorn, Elmer
    Simsek, Burcin
    Shen, Jun
    Pappo, Alberto
    EUROPEAN JOURNAL OF CANCER, 2017, 86 : 358 - 363
12345